Holden Leads Blog
Data, outreach strategies, and market intelligence for cannabis B2B professionals.
Trulieve and Glass House both trade below their NYSE debut prices a month in. What the first weeks of cannabis stocks on the NYSE actually signal.
Read more →Georgia's SB 220 took effect July 1. What its milligram caps and hemp crackdown say about where the cannabis edibles market is heading in 2026.
Read more →Virginia opened adult-use licensing, Missouri set a 77-license lottery, and Georgia expanded medical sales. The July 1 dispensary rule changes that matter.
Read more →B2B contact data decays 22-35% a year, and cannabis churns faster. Here's what actually breaks a dispensary contact list and how to tell if yours is dead.
Read more →Glass House hit the NYSE, Vireo paid $20M to enter Pennsylvania, and the Teamsters struck a grow. The week in cannabis deals and what it signals for B2B.
Read more →Pre-rolls overtook flower as cannabis's top category by units in 2026, led by infused pre-rolls. Here's the data and what the shelf shift means for B2B sellers.
Read more →Q1 2026 cannabis earnings split the big operators: Green Thumb grew revenue, Trulieve shrank but printed cash. Here's what it means for who can buy.
Read more →CBN, CBG, and THCV are 2026's anticipated breakout, with shoppers buying by blend over strain name. Here's what it means for dispensary shelves.
Read more →Most cannabis B2B outreach dies at the front desk. Here's how to reach the dispensary owner who can actually say yes, and why your channel matters.
Read more →DEA marijuana rescheduling hearing starts June 29, 2026. See what Schedule III already changed for licensed dispensaries, and what's still in play.
Read more →